Belgian Group of Digestive Oncology   Report issue

Foundation Phase 3
Founded: Zaventem Belgium (2003)

Organization Overview

First Clinical Trial
2020
NCT04257461
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Belgian Group of Digestive Oncology